CRISPR Therapeutics is a biopharmaceutical company created to translate CRISPR-Cas9
View all
Schrödinger
New York, United States · IPO
Quanterix
Billerica, United States · IPO
Neuralink
Fremont, United States · Secondary Market
Pathotrak
College Park, United States · Grant
ONI
San Diego, United States · Series B
Travere Therapeutics
San Diego, United States · Post IPO Equity
Akebia Therapeutics
Cambridge, United States · Post IPO Equity
Harbour BioMed
Cambridge, United States · IPO
Affinivax
Cambridge, United States · Grant
Butterfly Network
Guilford, United States · IPO
Longeveron
Miami, United States · IPO
Arcus Biosciences
Hayward, United States · Post IPO Equity